I would ask the member not to put words in my mouth. You may find disease examples where the catastrophic expenses are quite high. But for most people and the drugs that they access through our drug plans, that is not the case.
A co-payment is a common strategy in private insurance that works very well to increase access to pharmaceuticals and other health treatments. That is a private sector invention, by the way, and not something that was invented by governments. This works very well in the private sector for increasing access to pharmaceuticals.